Rhumbline Advisers Has $340.14 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Rhumbline Advisers raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 686,771 shares of the medical equipment provider's stock after buying an additional 2,044 shares during the quarter. Rhumbline Advisers owned about 0.19% of Intuitive Surgical worth $340,137,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also modified their holdings of the company. Onefund LLC raised its position in Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after acquiring an additional 18 shares in the last quarter. AlphaCore Capital LLC increased its stake in Intuitive Surgical by 4.2% during the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after acquiring an additional 18 shares during the last quarter. Journey Strategic Wealth LLC increased its holdings in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock valued at $542,000 after purchasing an additional 19 shares in the last quarter. FSM Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 3.7% during the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock valued at $275,000 after acquiring an additional 19 shares in the last quarter. Finally, Parkside Financial Bank & Trust increased its holdings in Intuitive Surgical by 2.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 747 shares of the medical equipment provider's stock worth $390,000 after purchasing an additional 19 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ISRG. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday. Evercore ISI cut their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Royal Bank of Canada dropped their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Finally, Citigroup reissued a "buy" rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $596.05.

Intuitive Surgical Price Performance

Shares of ISRG traded up $4.60 on Thursday, reaching $562.55. 344,385 shares of the stock traded hands, compared to its average volume of 1,643,166. Intuitive Surgical, Inc. has a 12 month low of $405.08 and a 12 month high of $616.00. The stock's 50-day moving average price is $519.52 and its 200-day moving average price is $538.95. The firm has a market cap of $201.63 billion, a price-to-earnings ratio of 87.76, a P/E/G ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period last year, the firm earned $1.50 earnings per share. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 215 shares of Intuitive Surgical stock in a transaction dated Wednesday, June 4th. The stock was sold at an average price of $552.07, for a total transaction of $118,695.05. Following the completion of the transaction, the senior vice president now owns 1,338 shares in the company, valued at approximately $738,669.66. This trade represents a 13.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. The trade was a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 25,716 shares of company stock valued at $12,831,288 in the last quarter. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.